8-KThe WireRoutine
Bylaw Amendment
Filed Oct 16, 2024 · 1y ago · Accession 0001628280-24-042948
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Aquestive Therapeutics, Inc.
- Ticker
- AQST
- CIK
- 1398733
- Form type
- 8-K
- Filing date
- Oct 16, 2024
- Report date
- Oct 16, 2024
- Document
- aqst-20241016.htm
- Size
- 5.9 MB